These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 845438)

  • 41. Generation of a neutrophil chemotactic agent by spermatozoa: role of complement and regulation by seminal plasma factors.
    Clark RA; Klebanoff SJ
    J Immunol; 1976 Oct; 117(4):1378-86. PubMed ID: 977954
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhancement of basophil chemotaxis in vitro by virus-induced interferon.
    Lett-Brown MA; Aelvoet M; Hooks JJ; Georgiades JA; Thueson DO; Grant JA
    J Clin Invest; 1981 Feb; 67(2):547-52. PubMed ID: 6161946
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Depression of polymorphonuclear chemotaxis and T-lymphocyte proliferation following histamine inhalation in man.
    Bury TB; Radermecker MF
    Eur Respir J; 1989 Oct; 2(9):828-33. PubMed ID: 2806507
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decreased releasability of basophils from patients with cold urticaria after cold exposure.
    Hessler HJ; Pufahl C; Christophers E
    Int Arch Allergy Appl Immunol; 1989; 89(2-3):236-41. PubMed ID: 2474511
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The inhibition of cutaneous basophil hypersensitivity reactions by a heterologous anti-guinea pig T cell serum.
    Stadecker MJ; Leskowitz S
    J Immunol; 1976 Jun; 116(6):1646-51. PubMed ID: 58042
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The basophil. Its morphology, biochemistry, motility, release reactions, recovery, and role in the inflammatory responses of IgE-mediated and cell-mediated origin.
    Dvorak AM; Dvorak HF
    Arch Pathol Lab Med; 1979 Oct; 103(11):551-7. PubMed ID: 582658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mediator release from basophil granulocytes in chronic myelogenous leukemia.
    Clark RA; Gallin JI; Kaplan AP
    J Allergy Clin Immunol; 1976 Dec; 58(6):623-34. PubMed ID: 62774
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of histamine in the chemotactic deactivation of polymorphonuclear leukocytes following incubation with formylmethionyl peptides.
    Bury T; Radermecker M
    Int Arch Allergy Immunol; 1992; 97(2):109-14. PubMed ID: 1316314
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanisms of hypersensitivity: cellular interactions. Basophil arrival and function in tissue hypersensitivity reactions.
    Askenase PW
    J Allergy Clin Immunol; 1979 Aug; 64(2):79-89. PubMed ID: 313413
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Purification of human blood basophils using negative selection by flow cytometry.
    Tanimoto Y; Takahashi K; Takata M; Kawata N; Kimura I
    Clin Exp Allergy; 1992 Nov; 22(11):1015-9. PubMed ID: 1281750
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antigen-induced histamine release from guinea pig basophils.
    Lett-Brown MA; Thueson DO; Grant JA
    Int Arch Allergy Appl Immunol; 1981; 64(3):241-8. PubMed ID: 6163732
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coagulation factors induce human skin mast cell and basophil degranulation via activation of complement 5 and the C5a receptor.
    Yanase Y; Matsuo Y; Takahagi S; Kawaguchi T; Uchida K; Ishii K; Tanaka A; Matsubara D; Ozawa K; Hide M
    J Allergy Clin Immunol; 2021 Mar; 147(3):1101-1104.e7. PubMed ID: 32888945
    [No Abstract]   [Full Text] [Related]  

  • 53. Potentiation of complement (C5a)-induced granulocyte aggregation by cytochalasin B.
    Craddock PR; White JG; Jacob HS
    J Lab Clin Med; 1978 Mar; 91(3):490-9. PubMed ID: 564378
    [No Abstract]   [Full Text] [Related]  

  • 54. Non-IgG1 nature of cutaneous basophil hypersensitivity factor in contact sensitivity. II. Demonstration of antigen-dependent basophil chemotactic activity of cutaneous basophil hypersensitivity factor.
    Katayama I; Nishioka K; Nishida K; Doi T
    Int Arch Allergy Appl Immunol; 1984; 73(4):289-95. PubMed ID: 6199313
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of cytokines on human basophil chemotaxis.
    Tanimoto Y; Takahashi K; Kimura I
    Clin Exp Allergy; 1992 Nov; 22(11):1020-5. PubMed ID: 1334781
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Study of possible mechanisms of basophil accumulation in experimental cutaneous candidiasis in guinea pigs.
    Sohnle PG; Kirkpatrick CH
    J Allergy Clin Immunol; 1977 Feb; 59(2):171-7. PubMed ID: 833382
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The in vitro effect of levamisole on lymphocyte proliferation, polymorphonuclear leucocyte chemotaxis, basophil histamine release and platelet serotonin release in patients with atopic dermatitis.
    O'Connor RD; Ring J; Jalowayski AA; Hamburger RN
    Clin Allergy; 1980 Nov; 10(6):705-13. PubMed ID: 6161718
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Depression of neutrophil chemotaxis in atopic individuals. An H2 histamine receptor response.
    Radermecker M; Maldague MP
    Int Arch Allergy Appl Immunol; 1981; 65(2):144-52. PubMed ID: 7228431
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Complement C5a receptor antagonism by protamine and poly-L-Arg on human leukocytes.
    Olsen UB; Selmer J; Kahl JU
    Complement; 1988; 5(3):153-62. PubMed ID: 3180741
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of histamine on chemotaxis and phagocytosis of human alveolar macrophages and blood monocytes.
    Radermecker M; Bury T; Saint-Remy P
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):197-9. PubMed ID: 2707883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.